Exelixis (EXEL) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $72.31 --0%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q3 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.77 million.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Studio City International Holdings Limited (MSC) Reports Q3 Loss of $0.02
- Neuronetics (STIM) Tops Q3 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
